Author: ALLISON GATLIN
Source
Merck’s Keytruda scored two important victories in women’s cancer, according to presentations Sunday at the ESMO meeting.
The post Merck Scores Two Key Victories With Keytruda In Women’s Cancers appeared first on Investor’s Business Daily.